NeoGenomics(NEO) - 2024 Q4 - Annual Results

Exhibit 99.1 NeoGenomics Reports Fourth Quarter and Full Year 2024 Results Full Year Revenue Increased 12% to $661 million; Ninth Consecutive Quarter of Double-Digit Revenue Growth Fort Myers, Florida, (February 18, 2025) - NeoGenomics, Inc. (Nasdaq: NEO) (the "Company"), a leading oncology testing services company, today announced its fourth-quarter and full year results for the period ended December 31, 2024. Fourth Quarter and Full Year 2024 Highlights "Our business continued to perform well throughout 2 ...